Solvonis Therapeutics plc (LSE: SVNS)
Health Care · Biotechnology · GB
£0.00
-4.76% today · -70.0% 1Y
Solvonis Therapeutics plc (LSE: SVNS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.53M and employs 6 people.
Over the last twelve months the share price has lost 70.0%, trading between 0.00 and 0.00.
Tweenvest scores Solvonis Therapeutics plc across four factors: quality 37/100, value 52/100. Its strongest factor is value.
SVNS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.53M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.19
- 52-week high
- £0.00
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.81B
- Employees
- 6
- Next earnings
- —
About Solvonis Therapeutics plc
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatry.
- ISIN
- GB00BMD1Z199
- Founded
- 2017
- Listed since
- Jan 6, 2022
- Exchange
- London Stock Exchange
- Currency
- GBP
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AtonENXTPA: ALTAO | $10.02M | €0.01 | -12.90% |
| China Regenerative Medicine International LimitedSEHK: 8158 | $9.89M | HK$0.26 | -17.74% |
| Theriva Biologics, Inc.NYSEAM: TOVX | $9.54M | $0.21 | -4.19% |
| Nextage Therapeutics LtdTASE: NXTG | $9.54M | ₪0.37 | -3.95% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $9.28M | $1.03 | -2.83% |
| Celestra Inc.KOSDAQ: A352770 | $9.28M | ₩— | — |
Figures last refreshed Oct 18, 2026.